Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch the on-demand webinar
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in:

01-06-2019 | Multiple Myeloma | Case report

Bortezomib, dexamethasone and lenalidomide

Syndrome of inappropriate secretion of antidiuretic hormone: case report

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Baba Y, et al. Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy. Rinsho Ketsueki 59: 2423-2427, No. 11, 2018. Available from: URL: http://​doi.​org/​10.​11406/​rinketsu.​59.​2423 [Japanese;summarised from a translation] - Japan
Metadata
Title
Bortezomib, dexamethasone and lenalidomide
Syndrome of inappropriate secretion of antidiuretic hormone: case report
Publication date
01-06-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63627-6

Other articles of this Issue 1/2019

Abacavir/dolutegravir/lamivudine

Cyclophosphamide/dexamethasone/etoposide

Avibactam/ceftazidime

Digoxin

Antitubercular drugs

Dapsone